Panel Discussion: Delving into the Regulatory Frameworks Governing the Use of Raw & Starting Materials, Including GMPs & Exploring Strategies to Achieve Compliance
Time: 3:15 pm
day: Conference Day 2
Details:
- Navigating current regulatory guidance on biological raw materials for ensuring approvals in all regions
- Discussing regulator’s expectation on translating from research to the clinic with proprietary materials to ensure patient safety and clinical approval
- Discussion on areas of future policy for cell and gene therapy raw and starting materials to accelerate development of safe, scalable and cost-effective therapies for patients
